RMTI Stock Analysis: Buy, Sell, or Hold?
RMTI - Rockwell Medical, Inc. (DE) Common Stock
$0.62
0.00 (0.35%)
▲
5d:
-5.97%
30d:
-22.01%
90d:
-30.28%
HOLD
LOW Confidence
Analysis Updated: Jun 12, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Get Alerted When RMTI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RMTI shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: RMTI shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: RMTI is currently trading at $0.62, which is considered oversold relative to its 30-day fair value range of $0.68 to $0.82. From a valuation perspective, the stock is trading at a discount (Forward PE: -125.0) compared to its historical average (17.3). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, RMTI is in a strong downtrend. The price is currently testing key support at $0.64. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: RMTI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (3th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $3.00 (+380.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RMTI is in a strong downtrend. The price is currently testing key support at $0.64. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: RMTI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (3th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $3.00 (+380.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.68 -
$0.82
Company Quality Score
52/100
(HOLD)
Options IV Signal
3th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
69.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 3th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 380.2% below Wall St target ($3.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- CAUTION: Recommendation downgraded due to -6.0% 5-day decline
Trading Range Analysis
30-Day Trading Range
$0.68 -
$0.82
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.23
(36.1%)
Support & Resistance Levels
Support Level
$0.64
Resistance Level
$0.79
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-124.96
Wall Street Target
$3.00
(+380.2%)
Revenue Growth (YoY)
-8.3%
Profit Margin
-8.0%
PE vs Historical
-125.0 vs 17.3
CHEAP
Share & Embed Analysis
Last updated: June 14, 2026 8:56 PM ET
Data refreshes hourly during market hours. Next update: 9:56 PM
Data refreshes hourly during market hours. Next update: 9:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RMTI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$193 | 64 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 60 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 65 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 57 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 59 HOLD |
